Cambridge University Press
0521858224 - Knowledge Accumulation and Industry Evolution - The Case of Pharma-Biotech - Edited by Mariana Mazzucato and Giovanni Dosi
Table of Contents
| List of figures | page ix | |||||
| List of tables | xii | |||||
| List of contributors | xiv | |||||
| Acknowledgments | xvii | |||||
| 1 | Introduction Giovanni Dosi and Mariana Mazzucato | 1 | ||||
| Part I Innovation and industry evolution | 19 | |||||
| 2 | Pharmaceutical innovation as a process of creative destruction Frank R. Lichtenberg | 21 | ||||
| 3 | The evolution of pharmaceutical innovation Paul Nightingale and Surya Mahdi | 73 | ||||
| 4 | Firm and regional determinants in innovation models: evidence from biotechnology and traditional chemicals Myriam Mariani | 112 | ||||
| 5 | Innovation and industry evolution: a comment Louis Galambos | 145 | ||||
| Part II Firm growth and market structure | 161 | |||||
| 6 | Heterogeneity and firm growth in the pharmaceutical industry Elena Cefis, Matteo Ciccarelli, and Luigi Orsenigo | 163 | ||||
| 7 | Growth and diversification patterns of the worldwide pharmaceutical industry Giulio Bottazzi, Fabio Pammolli, and Angelo Secchi | 208 | ||||
| 8 | Entry, market structure, and innovation in a “history-friendly” model of the evolution of the pharmaceutical industry Christian Garavaglia, Franco Malerba, and Luigi Orsenigo | 234 | ||||
| 9 | The growth of pharmaceutical firms: a comment Boyan Jovanovic | 266 | ||||
| Part III Policy implications | 275 | |||||
| 10 | The effects of research tool patents and licensing on biomedical innovation John P. Walsh, Ashish Arora, and Wesley M. Cohen | 277 | ||||
| 11 | Upstream patents and public health: the case of genetic testing for breast cancer Fabienne Orsi, Christine Sevilla, and Benjamin Coriat | 327 | ||||
| 12 | Competition, regulation, and intellectual property management in genetically modified foods: evidence from survey data Pierre Regibeau and Katharine Rockett | 346 | ||||
| 13 | Governance, policy, and industry strategies: pharmaceuticals and agro-biotechnology Joyce Tait, Joanna Chataway, Catherine Lyall, and David Wield | 378 | ||||
| 14 | The dynamics of knowledge accumulation, regulation, and appropriability in the pharma-biotech sector: policy issues Luigi Orsenigo, Giovanni Dosi, and Mariana Mazzucato | 402 | ||||
| Index | 432 | |||||
© Cambridge University Press